Contact
Contact page
Category & trade
Primary
cancer · embed-ft 0.47
Tree path
Medical Health › Diseases and Conditions › Cancer
Group (tier-1)
AI readiness
AI-Readiness score
24 / 100 · not-ready · see similar
AI training policy
allowed
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
MEFINDER — Multimodal Cancer AI Research
Description
MEFINDER is an NIH-funded multimodal cancer AI research initiative at Emory University's HITI Lab, integrating radiology, digital pathology, genomics, and EHR data to discover novel cancer phenotypes and deliver population-specific risk predictions for breast and prostate cancer.
Final URL
Language
en (html)
Scanned at
2026-07-09 05:49:04